Answers are grounded in this paper and cite their sources.
Retrospective study analyzes outcomes of postcardiotomy shock patients supported with VA-ECMO, indicating high mortality rates and complications.
Postcardiotomy shock (PCS) is an infrequent but severe complication. Initial management consists of pharmacological support; however, in refractory cases, circulatory support becomes necessary. The aim of this study is to analyze the characteristics of patients with PCS requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) implantation, and to compare complications and survival outcomes with the use of this support in other clinical scenarios. Methods: A descriptive, retrospective, single-centre study including all patients supported with VA-ECMO because of PCS between 2021 and 2025. Patients were categorized into three groups: PCS, cardiac arrest with VA-ECMO (ECPR) and patients whose etiology did not correspond to either of the previous categories (Non-PCS/ECPR). Results: A total of 147 VA-ECMO devices were implanted: 24.5% (n=36) for PCS, 29.9% (n=44) for ECPR, and 54% (n=67) for Non-PCS/ECPR. Variables from the EuroSCORE II were collected for the PCS group. Notably, 38.9% of patients presented in a critical preoperative condition. The EuroSCORE II showed a wide range, with a median of 9.2 [IQR: 3.2–21.8]. Regarding surgical type, 47.2% underwent coronary artery bypass grafting and 72.3% underwent valvular surgery. Most patients (n=22, 61.1%) underwent more than one procedure. The mean cardiopulmonary bypass duration was 249 ± 139 minutes, and the mean aortic cross-clamp time was 163 ± 85 minutes. Peripheral cannulation was used in 75.0% (n=27) of PCS cases and 47.2% (n=17) required a left ventricular unloading device, performed with an intra-aortic balloon pump in all cases. There were no significant differences in the unloading strategy compared with the ECPR group (52.8%, p=0.308) or the Non-PCS/ECPR group (43.3%, p=0.701). The incidence of complications during support was 72.2% (n=26) in the PCS group, not significantly different from ECPR (65.0%, p=0.499), although numerically higher than in Non-PCS/ECPR (52.0%, p=0.059). The most frequent complication in PCS was massive transfusion (77.1%, n=27). Hospital mortality in PCS was 69.4% (n=25). The most common causes of death were bleeding (28.0%, n=7), multiorgan failure (24.0%), and lack of recovery (20.0%). The ECPR group showed similar mortality (63.6%, p=0.585), but neurological injury was more frequent (42.9%). In the Non-PCS/ECPR group, mortality was significantly lower (44.8%, p=0.017), with multiorgan failure being the most frequent cause (43.3%). These survival differences persisted at one year follow-up. Conclusions: In our center, PCS patients requiring VA-ECMO are typically those undergoing urgent surgeries involving multiple procedures. The preoperative risk estimated by EuroSCORE II indicates a predicted mortality of 9.2%. In-hospital and one-year survival rates are comparable to those of ECPR but lower than those of Non-PCS/ECPR patients, although the pattern of complications differs, with a higher incidence of massive transfusion.
No takes yet. Share an insight, caveat, or question.
Orive et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: